SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001193125-20-141113
Filing Date
2020-05-13
Accepted
2020-05-13 08:21:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 FWP d812933dfwp.htm FWP 31582
2 GRAPHIC g812933g0513134622142.jpg GRAPHIC 14065
3 GRAPHIC g812933g0513134622500.jpg GRAPHIC 14321
4 GRAPHIC g812933g71p99.jpg GRAPHIC 50472
  Complete submission text file 0001193125-20-141113.txt   142271
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filed by) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Subject) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-238194 | Film No.: 20871131
SIC: 2836 Biological Products, (No Diagnostic Substances)